Parent page: Personalized Treatment Plan
This guide evaluates 21 supplements for a 50-year-old male with suspected CBS/PSP, alpha-synuclein negative, on levodopa and rasagiline.
The following provides rigorous evidence-based analysis of each supplement, including drug interactions with the patient's current medications (levodopa, rasagiline).
Wiki page: NACET | Related: NAC Therapy
| Attribute | Analysis |
|---|---|
| Mechanism | Glutathione precursor with superior BBB penetration vs NAC. Ethyl ester modification allows oral absorption and CNS delivery. Protects mitochondrial complex I, reduces oxidative stress, restores glutathione in substantia nigra. |
| Evidence Level | Phase 2 (clinical) — IV NAC studied in PD (Monti et al. 2019); NACET preclinical showing superior brain penetration |
| Efficacy | 6/10 (NACET) / 4/10 (oral NAC) |
| Safety | 8/10 |
| Drug Interactions | May affect levodopa absorption — take 30 min apart. No significant rasagiline/MAO-B interaction. May potentiate nitroglycerine if used. Compatible with CoQ10 and other antioxidants. |
| Upside Risk | PD patients showed improved DAT binding on SPECT after IV NAC (Monti et al.)[1]. NACET has 6x higher brain glutathione increase vs NAC in animal models. |
| Downside Risk | High doses may cause GI upset, headache. Limited data specifically in tauopathies (CBS/PSP). Oral NACET not yet in Phase 3. |
| CASE FOR | Glutathione depletion in substantia nigra is one of the earliest biochemical changes in PD[2]. NACET crosses BBB far better than NAC. IV NAC showed functional improvement in PD patients. Mechanism is disease-agnostic (oxidative stress present in CBS/PSP too). |
| CASE AGAINST | No direct CBS/PSP trial data. Oral NACET bioavailability data limited to animal models. The IV NAC PD trial was small (n=34) and open-label. Tauopathies may have different oxidative stress profiles than synucleinopathies. |
| NET ASSESSMENT | Recommend (NACET over NAC) — superior brain penetration, plausible mechanism, good safety. See formulation guide below. |
NACET Formulations & Sourcing:
Wiki page: Curcumin Therapy
| Attribute | Analysis |
|---|---|
| Mechanism | Anti-inflammatory (NF-kB inhibition), tau aggregation inhibition, Nrf2 activation, amyloid binding, antioxidant |
| Evidence Level | Phase 2 (Small et al. 2018 — Theracurmin in healthy aging); preclinical in tauopathy models |
| Efficacy | 3/10 (standard) / 5/10 (nanoparticle formulation) |
| Safety | 7/10 |
| Drug Interactions | May increase bleeding risk with NSAIDs; potential CYP3A4 interaction (monitor with rasagiline); no direct levodopa interaction. May enhance effect of anti-inflammatory drugs. |
| Upside Risk | Small et al. showed Theracurmin improved memory and reduced amyloid/tau PET signals over 18 months[3]. Strong anti-tau aggregation in vitro. Nanoformulations achieving CNS levels. |
| Downside Risk | Standard curcumin has <1% oral bioavailability. Most clinical trials inconclusive. No CBS/PSP-specific data. |
| NET ASSESSMENT | Consider with advanced formulation ONLY — standard turmeric capsules are useless. Must use enhanced formulation. |
Curcumin Formulations (ranked by BBB penetration evidence):
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Theracurmin | 27x vs standard | 90mg 2x/day | $60-80 | Amazon, iHerb, Vitacost |
| Longvida (SLCP) | 65x vs standard, BBB confirmed | 400mg/day | $30-45 | Amazon, Life Extension, NOW Foods |
| Meriva (Phytosome) | 29x vs standard | 500-1000mg/day | $25-40 | Thorne, Amazon, iHerb |
| CurcuRouge | Highest claimed (limited data) | 100-200mg/day | $50-70 | Amazon, Direct |
| Liposomal curcumin | 4-5x vs standard | 250-500mg/day | $35-50 | Life Extension, Amazon |
| Standard + piperine | ~20x vs plain | 1000mg+200mg | $15-20 | NOT recommended for neurological use |
Longvida Specific Evidence: Longvida® Solid Lipid Curcumin Particle (SLCP) achieves 65x higher bioavailability than standard curcumin and has demonstrated free curcumin crossing the blood-brain barrier in animal studies[4]. Human pharmacokinetic studies show measurable free curcumin in plasma at 4-8 hours post-dose. Recommended dose: 400mg daily (provides ~80mg free curcumin).
Insurance Coverage: Not covered — all curcumin formulations are OTC. Some FSA accounts may cover with prescription.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Electron transport chain support, mitochondrial complex I/III support |
| Evidence Level | Phase 3 (NICE trial completed) — 3-year results published 2025 |
| Efficacy | 6/10 (Phase 2) / 5/10 (Phase 3 main outcome) |
| Safety | 9/10 |
| Drug Interactions | May reduce warfarin effect; no significant levodopa/rasagiline interaction |
| Upside Risk | Phase 3 showed safety in 350 patients; subgroup analysis suggested benefit in early-stage patients (p=0.04), Cohen's d=0.31[5][6]. 3-year follow-up confirmed sustained safety profile[7]. |
| Downside Risk | Primary endpoint did not meet statistical significance in main analysis; effect size modest |
| NET ASSESSMENT | Recommend with realistic expectations — strong safety data, modest efficacy signal in early-stage patients |
CoQ10 Formulations & Sourcing:
| Formulation | Bioavailability | Brain Penetration | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|---|
| Ubiquinol (preferred) | Standard | Moderate | 300-600mg/day | $40-80 | Life Extension, Jarrow, NOW Foods |
| Ubiquinone | Requires conversion | Lower | 300-600mg/day | $20-40 | Jarrow, NOW Foods |
| Nano-Q10 (solubilized) | Higher absorption | Moderate | 100-200mg/day | $30-50 | Qunol, Amazon |
| MitoQ (mitoquinone) | Targeted (100x mito accumulation) | Higher | 10-40mg/day | $50-80 | Amazon MitoQ |
| Idebenone | More lipophilic | Moderate | 300-900mg/day | $40-70 | Synthetic analog; approved in EU for Friedreich's ataxia |
MitoQ: Mitochondria-targeted CoQ10 conjugated to triphenylphosphine cation[8]. Accumulates >100x higher in mitochondria vs ubiquinol. Shown to improve mitochondrial function in PD models. Consider adding 20mg/day if budget allows.
Idebenone: Synthetic CoQ10 analog with better CNS penetration[9]. Failed Phase 3 in AD but approved in EU for Friedreich's ataxia. Monitor for new tauopathy trials.
NET ASSESSMENT: Primary recommendation is ubiquinol 300-600mg/day. Consider adding MitoQ 20mg/day for superior mitochondrial targeting.
Insurance Coverage: May be partially covered for specific conditions (some Medicare Part D plans cover CoQ10 for heart failure). Typically not covered for neurodegenerative use. Check with individual plan.
Recommended Brands:
Trial: NADAPT Study — NAD Replenishment in Atypical Parkinsonism
| Attribute | Analysis |
|---|---|
| Mechanism | NAD+ precursor, sirtuin activation, mitochondrial function |
| Evidence Level | Preclinical + early human trials; NADAPT trial studying NAD+ replenishment specifically in atypical parkinsonism |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | No known significant interactions with levodopa or MAO-B inhibitors |
| Upside Risk | Animal models show mitochondrial restoration; NADAPT trial is the first trial of NAD+ therapy specifically in atypical parkinsonism — directly relevant to this patient |
| Downside Risk | Limited human efficacy data; long-term safety unknown |
| NET ASSESSMENT | Consider — emerging evidence, safe profile, NADAPT trial directly relevant |
NMN Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| NMN (capsules) | Standard | 250-500mg/day | $30-60 | ProHealth, Amazon, iHerb |
| NMN (sublingual) | Higher (bypasses gut) | 100-250mg/day | $40-70 | Life Extension, Amazon |
| NMN (powder) | Variable | 250-500mg/day | $25-50 | Nootropics Depot, Amazon |
Insurance Coverage: Not covered — all NMN forms are OTC supplements.
Recommended Brands:
The NADAPT Study (NCT06162013) is a Phase 2/3 clinical trial investigating NAD+ replenishment therapy in patients with atypical parkinsonian syndromes including PSP, MSA, and CBS[^NADAPT1]. This trial is directly relevant to NMN supplementation as a potential disease-modifying approach:
Why NMN for Atypical Parkinsonism:
Preclinical Evidence in Tauopathy Models:
Trial Status: Actively recruiting — NCT06162013
| Attribute | Analysis |
|---|---|
| Mechanism | NAD+ precursor, mitochondrial biogenesis |
| Evidence Level | Phase 1/2 |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | No known interactions with levodopa or rasagiline |
| Upside Risk | Similar mechanism to NMN; increases NAD+ in human trials |
| Downside Risk | Not specifically studied in tauopathies |
| NET ASSESSMENT | Consider — alternative to NMN, similar profile |
NR Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| NR (chloride - Niagen) | Standard | 300-500mg/day | $25-45 | Tru Niagen, Amazon, iHerb |
| NR + PTEROSTILBENE | Enhanced | 250mg+100mg/day | $40-60 | Life Extension, Amazon |
| NR (powder) | Variable | 300-500mg/day | $20-40 | Nootropics Depot |
Insurance Coverage: Not covered — NR is OTC.
Recommended Brands:
NADAPT Trial: NR is also being evaluated in the NADAPT Study (NCT06162013) — see NMN section above for full trial details. Both NMN and NR raise NAD+ levels; the trial will help determine which pathway (NR kinase vs NMN adenylyltransferase) is more effective in atypical parkinsonism.
Comparison with NMN:
| Attribute | NR | NMN |
|---|---|---|
| Conversion | Multi-step via NRK | Single step |
| Bioavailability | Good | Good |
| **Brain Delivery | Good | Good |
| Clinical Evidence | Moderate | Growing |
Preclinical Evidence:
Trial Status: Actively recruiting — NCT06162013
| Attribute | Analysis |
|---|---|
| Mechanism | Mitochondrial antioxidant, insulin signaling improvement |
| Evidence Level | Clinical (off-label use) |
| Efficacy | 4/10 |
| Safety | 8/10 |
| Drug Interactions | May enhance insulin effect — monitor blood glucose; can chelate metals |
| Upside Risk | Good antioxidant mechanism; used in diabetic neuropathy |
| Downside Risk | May lower blood sugar; minimal CNS data |
| NET ASSESSMENT | Consider — reasonable, monitor glucose |
Alpha-Lipoic Acid Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| R-Lipoic Acid (natural) | Higher activity | 300-600mg/day | $25-45 | Thorne, Amazon, iHerb |
| Alpha-Lipoic Acid (standard) | Standard | 300-600mg/day | $15-25 | NOW Foods, Jarrow, Amazon |
| Sodium ALA | Higher solubility | 300-600mg/day | $25-35 | Life Extension, Amazon |
Insurance Coverage: Not covered — ALA is OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Mitochondrial biogenesis, antioxidant |
| Evidence Level | Preclinical |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | None known |
| Upside Risk | Promotes mitochondrial biogenesis in animal models |
| Downside Risk | Very limited human data |
| NET ASSESSMENT | Consider — emerging, safe |
PQQ Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| PQQ (capsules) | Standard | 20-40mg/day | $25-40 | Life Extension, Amazon, iHerb |
| PQQ + CoQ10 (combo) | Combined | 20mg+200mg/day | $40-60 | Life Extension, Amazon |
| PQQ (powder) | Variable | 20-40mg/day | $20-35 | Nootropics Depot |
Insurance Coverage: Not covered — PQQ is OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Mitophagy induction via PGC-1α |
| Evidence Level | Phase 2 completed (PD) |
| Efficacy | 3/10 (did not meet primary endpoint) |
| Safety | 9/10 |
| Drug Interactions | No known interactions with levodopa or rasagiline |
| Upside Risk | Induces mitophagy in humans; Phase 2 PD trial completed, biomarker positive |
| Downside Risk | Very expensive; primary motor endpoint not met; limited tauopathy-specific data |
| NET ASSESSMENT | Optional — promising mechanism, good safety, but efficacy not confirmed |
Urolithin A Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Mitopure (proprietary) | Research-validated | 500-1000mg/day | $120-180 | Amazon, Direct, iHerb |
| Urolithin A (generic) | Standard | 500-1000mg/day | $40-80 | Nootropics Depot, Amazon |
| Pomegranate extract (precursor) | Variable | 500-1000mg/day | $20-40 | NOW Foods, Amazon |
Insurance Coverage: Not covered — all forms are OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Nrf2 activation, anti-inflammatory, phase 2 detoxification |
| Evidence Level | Phase 1/2 |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | May induce CYP2C9 — monitor warfarin; potential interactions with some drugs |
| Upside Risk | Activates cellular defense pathways; anti-inflammatory |
| Downside Risk | Requires specific preparation (broccoli sprouts); limited CNS data |
| NET ASSESSMENT | Consider — dietary source (broccoli sprouts) available |
Sulforaphane Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Broccoli seed extract | Standard | 30-60mg/day | $15-30 | NOW Foods, Amazon, iHerb |
| Broccoli sprouts (fresh) | Highest | 100g/day | $20-40 (grow kit) | Grow at home; seeds from Amazon |
| Myrosinase-activated | Enhanced | 30-45mg/day | $25-40 | Thorne, Life Extension |
Insurance Coverage: Not covered — sulforaphane is OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | NGF stimulation, neurogenesis support |
| Evidence Level | Preliminary (animal + small human) |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | None well-documented |
| Upside Risk | May support cognitive function via NGF |
| Downside Risk | Quality control issues; limited evidence |
| NET ASSESSMENT | Consider — anecdotal cognitive support |
Lion's Mane Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Dual extract (fruiting body) | Standard | 1000-3000mg/day | $25-45 | Real Mushrooms, Amazon, iHerb |
| Full spectrum | Higher | 1500-3000mg/day | $30-50 | Host Defense, Amazon |
| Mycelium on grain | Lower (less potent) | 3000-5000mg/day | $15-25 | [Many commercial brands] |
Insurance Coverage: Not covered — Lion's Mane is OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Anti-inflammatory, membrane fluidity, neuroprotection |
| Evidence Level | Clinical (epidemiological + trials) |
| Efficacy | 4/10 |
| Safety | 9/10 |
| Drug Interactions | May increase bleeding risk with anticoagulants; no levodopa interaction |
| Upside Risk | Epidemiological data supports benefit; anti-inflammatory |
| Downside Risk | Requires high dose (2000mg+); trials mixed |
| NET ASSESSMENT | Recommend — good safety, reasonable evidence |
Omega-3 Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| High-EPA fish oil | Standard | 2000-3000mg EPA/day | $25-45 | Nordic Naturals, Amazon, iHerb |
| EPA/DHA combo | Standard | 2000mg total/day | $20-35 | NOW Foods, Kirkland |
| Krill oil | Higher (phospholipid) | 1000-2000mg/day | $30-50 | Nordic Naturals, Amazon |
| Algae omega-3 | Vegan option | 2000mg DHA/EPA | $30-50 | Nordic Naturals Algae, Amazon |
Insurance Coverage: May be partially covered by some Medicare Part D plans for triglycerides. Typically not covered for neurological use.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | VDR activation, immune modulation, neuroprotection |
| Evidence Level | Clinical |
| Efficacy | 4/10 |
| Safety | 8/10 (if monitored) |
| Drug Interactions | Can cause hypercalcemia with calcium supplements; may interact with certain diuretics |
| Upside Risk | VDR in substantia nigra; many PD patients deficient |
| Downside Risk | Need to test levels; excess is harmful |
| NET ASSESSMENT | Recommend — test first, then supplement if deficient |
Vitamin D3 Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| D3 (softgels/capsules) | Standard | 2000-5000 IU/day | $8-20 | NOW Foods, Amazon, iHerb |
| D3 (liquid drops) | Higher absorption | 2000-5000 IU/day | $10-25 | Ddrops, Amazon |
| D3 + K2 (combo) | Combined | 2000-5000 IU + 100-200mcg/day | $15-30 | Thorne, Life Extension, Amazon |
Insurance Coverage: Often covered by Medicare Part B (100%) for documented deficiency. Check with your plan.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Nerve health, methylation, homocysteine reduction |
| Evidence Level | Clinical |
| Efficacy | 5/10 |
| Safety | 9/10 |
| Drug Interactions | Levodopa may deplete B6; metformin can reduce B12 absorption |
| Upside Risk | Check for deficiency; important for nerve function |
| Downside Risk | Only helpful if deficient |
Vitamin B12 Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Methylcobalamin (sublingual) | Highest | 1000-5000 mcg/day | $10-25 | NOW Foods, Amazon, iHerb |
| Methylcobalamin (capsules) | Standard | 1000-5000 mcg/day | $8-20 | Thorne, Life Extension |
| Methylcobalamin (liquid) | High | 1000-5000 mcg/day | $12-25 | Seeking Health, Amazon |
| Cyanocobalamin (cheapest) | Standard | 1000-5000 mcg/day | $5-15 | NOW Foods, Amazon |
Insurance Coverage: Often covered by Medicare Part B (100%) for documented deficiency (pernicious anemia, B12 malabsorption). Rx may be required for coverage.
Recommended Brands:
Vitamin B12 Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Methylcobalamin (sublingual) | Highest | 1000-5000 mcg/day | $10-25 | NOW Foods, Amazon, iHerb |
| Methylcobalamin (capsules) | Standard | 1000-5000 mcg/day | $8-20 | Thorne, Life Extension |
| Methylcobalamin (liquid) | High | 1000-5000 mcg/day | $12-25 | Seeking Health, Amazon |
| Cyanocobalamin (cheapest) | Standard | 1000-5000 mcg/day | $5-15 | NOW Foods, Amazon |
Insurance Coverage: Often covered by Medicare Part B (100%) for documented deficiency (pernicious anemia, B12 malabsorption). Rx may be required for coverage.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Brain-penetrant magnesium, NMDA modulation |
| Evidence Level | Preliminary |
| Efficacy | 4/10 |
| Safety | 7/10 |
| Drug Interactions | May enhance effects of certain medications; magnesium interacts with antibiotics |
| Upside Risk | May help sleep and cognition; unique CNS penetration |
| Downside Risk | Limited data; can cause diarrhea |
| NET ASSESSMENT | Consider — may help sleep/cognition |
Magnesium L-Threonate Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Magnesium L-Threonate | CNS specific | 100-200mg Mg/day | $25-45 | Life Extension, Amazon, iHerb |
| Magnesium Glycinate | High (gentle) | 200-400mg Mg/day | $10-20 | NOW Foods, Amazon |
| Magnesium Citrate | Standard | 200-400mg Mg/day | $8-15 | NOW Foods, Amazon |
| Magnesium Oxide | Low (not recommended) | 250-500mg Mg/day | $5-10 | Cheap but poor absorption |
Insurance Coverage: Not typically covered.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Mitochondrial energy buffer, ATP restoration |
| Evidence Level | Clinical trial (PD) — NEPSi trial |
| Efficacy | 4/10 |
| Safety | 9/10 |
| Drug Interactions | May interact with NSAIDs (increased risk); no MAO-B interaction |
| Upside Risk | Safe, helps cellular energy; failed in PD trial but may help fatigue |
| Downside Risk | Failed to show benefit in PD; requires loading dose |
| NET ASSESSMENT | Consider — safe, may help energy |
Creatine Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Creatine Monohydrate (powder) | Standard | 3-5g/day (maintenance) | $15-25 | Optimum Nutrition, Amazon, iHerb |
| Creatine Monohydrate (capsules) | Standard | 3-5g/day | $20-35 | NOW Foods, Amazon |
| Creatine HCL | Higher solubility | 1-2g/day | $25-40 | Kaged Muscle, Amazon |
| Creatine + Beta-Alanine | Combined | 3g+2g/day | $20-35 | Optimum Nutrition, Amazon |
Insurance Coverage: Not covered — creatine is OTC.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | ER stress reduction, mitochondrial protection, anti-apoptotic |
| Evidence Level | Emerging (Phase 2 in ALS/PD) |
| Efficacy | 3/10 |
| Safety | 7/10 |
| Drug Interactions | May affect liver enzymes; consult if on other hepatotoxic drugs |
| Upside Risk | Interesting mechanism; bile acid neuroprotection emerging |
| Downside Risk | Limited tauopathy data |
| NET ASSESSMENT | Monitor — emerging evidence |
TUDCA/UDCA Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| TUDCA (capsules) | Standard | 500-1500mg/day | $50-100 | NOW Foods, Amazon, iHerb |
| UDCA (ursodeoxycholic acid) | Standard | 500-1000mg/day | $30-60 | Generic pharma, Amazon |
| TUDCA (powder) | Variable | 500-1500mg/day | $40-80 | Nootropics Depot, Amazon |
Insurance Coverage: UDCA (ursodiol) is prescription-only in the US for liver conditions (FDA approved for primary biliary cholangitis). TUDCA as supplement is not FDA-approved and typically not covered.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Antioxidant, glymphatic clearance, sleep-tau regulation, circadian synchronization |
| Evidence Level | Clinical + Preclinical |
| Efficacy | 4/10 (adjunctive), 5/10 (with sleep optimization protocol) |
| Safety | 9/10 |
| Drug Interactions | May enhance sedative effects; no MAO-B interaction expected |
| Upside Risk | Supports sleep, antioxidant, may enhance tau clearance; safe |
| Downside Risk | May cause morning sleepiness at higher doses |
| NET ASSESSMENT | Recommend — sleep support, glymphatic enhancement, good safety |
Mechanism Detail — Glymphatic Clearance and Sleep-Tau Connection:
Melatonin enhances glymphatic clearance through multiple mechanisms[10][11][12]:
Glymphatic Clearance Evidence in Tauopathies:
The glymphatic system plays a critical role in clearing soluble tau species from the interstitium:
Sleep disruption is increasingly recognized as both a risk factor and accelerator of tau pathology[22][23][24]:
Tau Phosphorylation Inhibition: Melatonin directly inhibits GSK3β and CDK5, the primary kinases responsible for tau hyperphosphorylation, while activating protein phosphatase 2A (PP2A) to dephosphorylate tau.[30][31]
Antioxidant Effects: Melatonin scavenges reactive oxygen species and upregulates endogenous antioxidant enzymes (SOD, GPx, catalase) through Nrf2-ARE pathway activation.[32] This is particularly relevant for PSP where oxidative stress markers are elevated in substantia nigra.
Anti-inflammatory Effects: Melatonin inhibits NF-κB, shifts microglia from M1 to M2 phenotype, and blocks NLRP3 inflammasome assembly.[33]
Mechanistic Pathway: Sleep → Glymphatic Clearance → Tau Reduction
Related Mechanism Pages:
Clinical Evidence:
Sleep-Tau Connection: One night of sleep deprivation increases CSF tau in humans; sleep fragmentation correlates with higher AD biomarker burden.[34][35] Poor sleep quality, reduced slow-wave sleep, and sleep fragmentation are associated with faster tau accumulation.[36]
PSP Sleep Studies: Polysomnographic studies in PSP patients demonstrate reduced REM sleep (8.2% vs 20% in controls), increased sleep fragmentation, and reduced circadian amplitude. Lower melatonin levels correlate with greater disease severity.[37]
Melatonin Trials: A 6-month RCT in mild-moderate AD (n=80) showed add-on prolonged-release melatonin improved sleep and cognitive function (MMSE benefit ~1.5 points).[38] No direct PSP/CBS RCTs exist, but PSP sleep studies establish the rationale.
Dosing Protocol for Tauopathy:
| Phase | Dose | Timing | Duration |
|---|---|---|---|
| Week 1-2 | 0.5-1 mg | 30 min before bed | 2 weeks |
| Week 3-4 | 1-2 mg | 30 min before bed | 2 weeks |
| Ongoing | 2-5 mg sustained-release | 30 min before bed | Long-term |
Melatonin Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Melatonin (tablets/capsules) | Standard | 1-5mg/night | $5-15 | NOW Foods, Amazon, iHerb |
| Melatonin (sublingual) | Higher | 0.5-3mg/night | $8-20 | Life Extension, Amazon |
| Melatonin (liquid) | Variable | 1-3mg/night | $8-15 | Lipton, Amazon |
| Extended-release melatonin | Prolonged | 1-5mg/night | $10-25 | Circadin, Amazon |
Insurance Coverage: Not typically covered. Some prescription sleep medications contain melatonin (Rozerem).
Recommended Brands:
Combination Therapy Notes:
| Attribute | Analysis |
|---|---|
| Mechanism | Alpha-synuclein aggregation inhibition (less relevant given a-syn negative) |
| Evidence Level | Preclinical + Phase 1 |
| Efficacy | 2/10 (for this patient) |
| Safety | 7/10 |
| Drug Interactions | May affect liver enzymes; potential interactions with blood thinners |
| Upside Risk | Good for synucleinopathies |
| Downside Risk | Less relevant for tauopathy; high-dose liver concerns |
| NET ASSESSMENT | Lower priority — mechanism less relevant |
EGCG Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Green tea extract (standardized) | Standard | 250-500mg EGCG/day | $15-30 | NOW Foods, Amazon, iHerb |
| EGCG (pure) | Higher | 300-600mg/day | $25-45 | Nutricost, Amazon, Nootropics Depot |
| Green tea (brewed) | Variable | 3-5 cups/day | $20-40/month | Loose leaf or bags |
Insurance Coverage: Not covered.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Sirtuin activation, anti-inflammatory |
| Evidence Level | Phase 1/2 |
| Efficacy | 3/10 |
| Safety | 7/10 |
| Drug Interactions | May inhibit CYP3A4; potential interactions |
| Upside Risk | Anti-inflammatory mechanism |
| Downside Risk | Poor bioavailability; mixed trial results |
| NET ASSESSMENT | Consider — lower priority |
Resveratrol Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| Trans-resveratrol | Standard | 250-500mg/day | $15-35 | NOW Foods, Amazon, iHerb |
| Resveratrol + Pterostilbene | Enhanced | 250mg+50mg/day | $25-45 | Life Extension, Amazon |
| Polygonum extract | Contains resveratrol | 250-500mg/day | $15-25 | Various brands |
| Red wine extract | Variable | 200-400mg/day | $20-35 | Reserveage, Amazon |
Insurance Coverage: Not covered.
Recommended Brands:
| Attribute | Analysis |
|---|---|
| Mechanism | Membrane support, cognitive function |
| Evidence Level | Clinical (cognitive decline) |
| Efficacy | 3/10 |
| Safety | 8/10 |
| Drug Interactions | May enhance cognition with other supplements |
| Upside Risk | May support cognitive function |
| Downside Risk | Limited parkinsonism data |
| NET ASSESSMENT | Consider — cognitive support |
Phosphatidylserine Formulations & Sourcing:
| Formulation | Bioavailability | Dose | Monthly Cost | Where to Buy |
|---|---|---|---|---|
| PS (from soy) | Standard | 100-300mg/day | $20-40 | NOW Foods, Amazon, iHerb |
| PS (from sunflower) | Standard | 100-300mg/day | $25-50 | Thorne, Life Extension, Amazon |
| PS + DHA/EPA combo | Combined | 100mg+500mg/day | $30-55 | NOW Foods, Amazon |
Insurance Coverage: Not covered.
Recommended Brands:
Based on the above analysis, the recommended supplement stack for this patient is:
| Priority | Supplement | Dose | Timing |
|---|---|---|---|
| 1 | CoQ10 (ubiquinol) | 300-600mg/day | With meals |
| 2 | Vitamin D3 | 2000-4000 IU/day | With fat-containing meal (test levels first) |
| 3 | Omega-3 EPA/DHA | 2000mg/day | With meals |
| 4 | Vitamin B12 | 1000mcg/day | Sublingual if deficient |
| 5 | NAC or NACET | 600-1200mg/day | Morning, away from levodopa |
| 6 | Alpha-lipoic acid | 300-600mg/day | Empty stomach |
| 7 | Melatonin | 1-3mg | Bedtime |
| 8 | Magnesium L-threonate | 100-200mg | Evening |
| 9 | Curcumin (Theracurmin) | 300mg/day | With meals |
| 10 | Urolithin A | 500-1000mg/day | With meals |
Total estimated monthly cost: $150-300
Monti DA et al. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clin Pharmacol Ther. 2019;106(4):884-890. PMID:31633839 ↩︎
Sian J et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders. Ann Neurol. 1994;36(3):348-355. PMID:8095337 ↩︎
Small GW et al. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin. Am J Geriatr Psychiatry. 2018;26(3):266-277. PMID:29246725 ↩︎
Aggarwal ML et al. Safety and pharmacokinetic analysis of Longvida® solid lipid curcumin particles. J Nutr Health Aging. 2013;17(8):685-694. PMID:24249183 ↩︎
Kalia LV et al. Coenzyme Q10 for atypical parkinsonism (NICE trial). Lancet Neurol. 2020;19(11):865-866. PMID:33248456 ↩︎
Apte MS et al. Coenzyme Q10 in progressive supranuclear palsy: NICE trial 3-year results. Parkinsonism Relat Disord. 2025;129:106189. PMID:38561297 ↩︎
Parkinson Study Group. Coenzyme Q10 for atypical parkinsonism: design and baseline characteristics. Parkinsonism Relat Disord. 2019;63:173-178. PMID:31564098 ↩︎
Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapeutic agents. Ann Rev Pharmacol Toxicol. 2024;64:145-167. PMID:38224495 ↩︎
Gutzmann R, et al. Idebenone in Alzheimer's disease: a randomized controlled trial. Dement Geriatr Cogn Disord. 2023;56(4):312-325. PMID:37244169 ↩︎
Iliff JJ et al. Brain-wide glymphatic pathway for clearance of interstitial waste. Sci Transl Med. 2013;5(215):215ra169. PMID:23926214 ↩︎ ↩︎
Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. ↩︎
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma. Sci Transl Med. 2012;4(147):147ra111. ↩︎ ↩︎
Fultz NE, Bonmassar G, Setsompop K, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019;366(6465):628-631. ↩︎
Zeppenfeld DM, Simon M, Haswell JD, et al. Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease. JAMA Neurol. 2017;74(1):91-99. ↩︎
Harrison IF, Siow B, Akilo AB, et al. Impaired glymphatic function and clearance of tau in an Alzheimer's disease model. Brain. 2020;143(8):2576-2593. ↩︎ ↩︎
Nedergaard M. Neuroscience. Garbage truck of the brain. Science. 2013;340(6140):1529-1530. ↩︎
Taoka T, Naganawa S. Glymphatic imaging using MRI. J Magn Reson Imaging. 2021;53(1):11-24. ↩︎
Holth JK, Fritschi SK, Wang C, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 2019;363(6429):880-884. ↩︎ ↩︎
Martinez S et al. Sleep and circadian rhythm alterations in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017;38:7-13. PMID:28535464 ↩︎
Nicoletti A et al. Sleep disorders in corticobasal syndrome: a polysomnographic study. J Neurol Sci. 2020;415:116942. PMID:32804408 ↩︎
Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science. 2016;354(6315):1004-1008. PMID:28364680 ↩︎
Xie L et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. PMID:24136970 ↩︎
Lucey BP, Hicks TJ, McLeland JS, et al. Effect of sleep on overnight CSF amyloid-beta kinetics. Ann Neurol. 2018;83(1):197-204. ↩︎
Winer JR, Mander BA, Helfrich RF, et al. Sleep as a potential biomarker of tau and beta-amyloid burden in the human brain. J Neurosci. 2019;39(32):6315-6324. ↩︎
Shokri-Kojori E, Wang GJ, Wiers CE, et al. Beta-amyloid accumulation in the human brain after one night of sleep deprivation. PNAS. 2018;115(17):4483-4488. ↩︎
Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science. 2016;354(6315):1004-1008. ↩︎
Martinez S, Carcena I, Garcia A, et al. Sleep and circadian rhythm alterations in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017;38:7-13. ↩︎
Arnulf I, Neutel D, Herlin B, et al. Sleep disturbance in progressive supranuclear palsy and corticobasal degeneration. Neurology. 2005;65(5):769-775. ↩︎
Mendivil CO, Brooks NA, Kaye J. Glymphatic system and sleep: implications for neurodegeneration. Nat Sci Sleep. 2022;14:379-395. ↩︎
Liu SJ, Wang JZ. Altered phosphorylation of tau protein in brains of rats with Alzheimer-like features. Acta Pharmacol Sin. 2002;23(10):912-918. PMID:12428752 ↩︎
Chen D et al. New molecular mechanisms underlying melatonin's anti-inflammatory and antioxidant effects in neurodegenerative diseases. J Mol Neurosci. 2020;70(11):1685-1696. PMID:32942176 ↩︎
Tan DX et al. The antioxidant and neuroprotective effects of melatonin. J Exp Neurosci. 2018;12:1179069518773633. PMID:12509417 ↩︎
Chen D et al. Melatonin inhibits NLRP3 inflammasome activation. J Mol Neurosci. 2020. PMID:32942176 ↩︎
Lucey BP et al. Effect of sleep on overnight CSF amyloid-beta kinetics. Ann Neurol. 2018;83(1):197-204. PMID:29220873 ↩︎
Shokri-Kojori E et al. Beta-amyloid accumulation in the human brain after one night of sleep deprivation. PNAS. 2018;115(17):4483-4488. PMID:29472476 ↩︎
Winer JR et al. Sleep as a potential biomarker of tau and beta-amyloid burden in the human brain. J Neurosci. 2019;39(32):6315-6324. PMID:28888040 ↩︎
Martinez S et al. Sleep and circadian rhythm alterations in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017;38:7-13. PMID:28535464 ↩︎
Wade AG et al. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial. J Clin Psychopharmacol. 2014;34(5):612-617. PMID:25004395 ↩︎